March-April 2006 - Volume 29 - Issue 2 - Contributor Index

Alphabetical Search
A
C
I
O
Q
T
U
V
X
Z
Author:
Bremen, Dirk MD
Author:
Dorow, R.

Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis

Hofmann, C.; Penner, U.; Dorow, R.; More

Clinical Neuropharmacology. 29(2):80-86, March-April 2006.

Author:
Hofmann, C.

Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis

Hofmann, C.; Penner, U.; Dorow, R.; More

Clinical Neuropharmacology. 29(2):80-86, March-April 2006.

Author:
Horowski, R.

Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis

Hofmann, C.; Penner, U.; Dorow, R.; More

Clinical Neuropharmacology. 29(2):80-86, March-April 2006.

Author:
Jähnichen, S.

Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis

Hofmann, C.; Penner, U.; Dorow, R.; More

Clinical Neuropharmacology. 29(2):80-86, March-April 2006.

Author:
Latté, K. P.

Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis

Hofmann, C.; Penner, U.; Dorow, R.; More

Clinical Neuropharmacology. 29(2):80-86, March-April 2006.

Author:
Palla, D.

Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis

Hofmann, C.; Penner, U.; Dorow, R.; More

Clinical Neuropharmacology. 29(2):80-86, March-April 2006.

Author:
Penner, U.

Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis

Hofmann, C.; Penner, U.; Dorow, R.; More

Clinical Neuropharmacology. 29(2):80-86, March-April 2006.

Author:
Pertz, H. H.

Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis

Hofmann, C.; Penner, U.; Dorow, R.; More

Clinical Neuropharmacology. 29(2):80-86, March-April 2006.

Author:
Schurad, B.

Lisuride, a Dopamine Receptor Agonist With 5-HT2B Receptor Antagonist Properties: Absence of Cardiac Valvulopathy Adverse Drug Reaction Reports Supports the Concept of a Crucial Role for 5-HT2B Receptor Agonism in Cardiac Valvular Fibrosis

Hofmann, C.; Penner, U.; Dorow, R.; More

Clinical Neuropharmacology. 29(2):80-86, March-April 2006.

Author:
Yoon, Gihyun MD
Show: